The application of adenoviral gene therapy for cancer is limited by immune clearance of the virus as well as poor transduction efficiency, since the protein used for viral entry (CAR) serves physiological functions in adhesion and is frequently decreased among cancer cells. Cationic polymers have been used to enhance adenoviral gene delivery, but novel polymers with low toxicity are needed to realize this approach. We recently identified polymers that were characterized by high transfection efficiency of plasmid DNA and a low toxicity profile. In this study we evaluated the novel cationic polymer EGDE-3,3' for its potential to increase adenoviral transduction of the CAR-negative bladder cancer cell line TCCSUP. The amount of adenovirus required to transduce 50-60% of the cells was reduced 100-fold when Ad.GFP was preincubated with the EGDE-3,3' polymer. Polyethyleneimine (pEI), a positively charged polymer currently used as a standard for enhancing adenoviral transduction, also increased infectivity, but transgene expression was consistently higher with EGDE-3,3'. In addition, EGDE-3,3'-supplemented transduction of an adenovirus expressing an apoptosis inducing transgene, Ad.GFP-TRAIL, significantly enhanced the amount of cell death. Thus, our results indicate that novel biocompatible polymers may be useful in improving the delivery of adenoviral gene therapy.
The application of adenoviral gene therapy for cancer is limited by immune clearance of the virus as well as poor transduction efficiency, since the protein used for viral entry (n class="Gene">CAR) serves physiological functions in adhesion and is frequently decreased among cancer cells. Cationic polymers have been used to enhance adenoviral gene delivery, but novel polymers with low toxicity are needed to realize this approach. We recently identified polymers that were characterized by high transfection efficiency of plasmid DNA and a low toxicity profile. In this study we evaluated the novel cationic polymerEGDE-3,3' for its potential to increase adenoviral transduction of the CAR-negative bladder cancer cell line TCCSUP. The amount of adenovirus required to transduce 50-60% of the cells was reduced 100-fold when Ad.GFP was preincubated with the EGDE-3,3' polymer. Polyethyleneimine (pEI), a positively charged polymer currently used as a standard for enhancing adenoviral transduction, also increased infectivity, but transgene expression was consistently higher with EGDE-3,3'. In addition, EGDE-3,3'-supplemented transduction of an adenovirus expressing an apoptosis inducing transgene, Ad.GFP-TRAIL, significantly enhanced the amount of cell death. Thus, our results indicate that novel biocompatible polymers may be useful in improving the delivery of adenoviral gene therapy.
Authors: Sutapa Barua; Amit Joshi; Akhilesh Banerjee; Dana Matthews; Susan T Sharfstein; Steven M Cramer; Ravi S Kane; Kaushal Rege Journal: Mol Pharm Date: 2009 Jan-Feb Impact factor: 4.939
Authors: Vladimir Subr; Libor Kostka; Tom Selby-Milic; Kerry Fisher; Karel Ulbrich; Leonard W Seymour; Robert C Carlisle Journal: J Control Release Date: 2008-12-30 Impact factor: 9.776
Authors: Elena Seiradake; Daniel Henaff; Harald Wodrich; Olivier Billet; Matthieu Perreau; Claire Hippert; Franck Mennechet; Guy Schoehn; Hugues Lortat-Jacob; Hanna Dreja; Sandy Ibanes; Vasiliki Kalatzis; Jennifer P Wang; Robert W Finberg; Stephen Cusack; Eric J Kremer Journal: PLoS Pathog Date: 2009-01-02 Impact factor: 6.823
Authors: Chung-Huei K Wang; Leslie W Chan; Russell N Johnson; David S H Chu; Julie Shi; Joan G Schellinger; André Lieber; Suzie H Pun Journal: Biomaterials Date: 2011-09-28 Impact factor: 12.479
Authors: Helen Gosnell; Laura M Kasman; Thrimoorthy Potta; Lucas Vu; Elizabeth Garrett-Mayer; Kaushal Rege; Christina Voelkel-Johnson Journal: J Control Release Date: 2013-12-24 Impact factor: 9.776